Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity

A recombinant Newcastle Disease Virus (NDV), encoding either a human (NDVhuGM-CSF, MEDI5395) or murine (NDVmuGM-CSF) GM-CSF transgene, combined broad oncolytic activity with the ability to significantly modulate genes related to immune functionality in human tumor cells. Replication in murine tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Harper, James, Burke, Shannon, Travers, Jon, Rath, Nicola, Leinster, Andrew, Navarro, Christel, Franks, Ruth, Leyland, Rebecca, Mulgrew, Kathy, McGlinchey, Kelly, Brown, Lee, Dovedi, Simon J., Koopmann, Jens-Oliver, Durham, Nicholas M., Cheng, Xing, Jin, Hong, Eyles, Jim, Wilkinson, Robert W., Carroll, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Large Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398146/
https://www.ncbi.nlm.nih.gov/pubmed/34224361
http://dx.doi.org/10.1158/1535-7163.MCT-20-0902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398146/
https://www.ncbi.nlm.nih.gov/pubmed/34224361
http://dx.doi.org/10.1158/1535-7163.MCT-20-0902

Ejemplares similares